Judge Set to Rule on Oklahoma’s Case Against J&J
Judge Balkman will decide Oklahoma’s J&J case next week.
Drugs & Medical Devices
Polster Considers Lawyers Proposal for Consolidated Opioid Litigation
Judge Dan Polster considers a recommended strategy for bring all locales into consolidated litigation.
Amgen’s Enbrel Patents Upheld, Copycat from Novartis Denied
Amgen’s drug patent upheld and Novartis’s copycat version is denied.
California Seeks to Stop Pay-to-delay Generic Drug Agreements
Three of the top pharmaceutical companies have entered agreements to pay the state of California nearly $70 million to settle allegations that they “delayed drugs to keep prices high” according to California Attorney General Xavier Becerra. Most of the funds will come from Teva Pharmaceuticals ($69 million) for paying to delay a generic for Provigil,
Novartis Provided False Data to Win Zolgensma Approval, FDA Says
Novartis manipulated data to win approval for its spinal muscular atrophy treatment.
Connecticut Joins Effort to Investigate JUUL’s Marketing Efforts
Connecticut is joining in on an investigation into JUUL’s marketingn efforts.
Restrictions Placed on One-time Opioid Supplies
The Trump Administration follows the lead of some states and restricts short-term opioid use to seven days.
Know More About Hepatitis C and Medicines Used for Its Treatment
What do you know about Hepatitis C and its treatment? Being an informed patient is helpful to successful outcomes.
Opioid Distributors and AGs Try to Negotiate Settlement in Billions
Cardinal Health, McKesson, and AmerisourceBergen have proposed paying $10 billion to settle all claims that they contributed to the opioid crisis. All three opioid distributors have been hit hard with claims that they did not do enough to flag and discontinue shipping large, suspicious orders of addictive drugs. The companies made the verbal proposal with
Opioid Settlement Funds Need to be Used Correctly, Experts Say
Opioid settlement needs to have more directon than the tobacco one, experts say.